Catalia Health, a San Francisco, CA-based patient care management company, closed a $4m pre-Series A funding round.
The round was led by Ion Pacific, with participation from Khosla Ventures, NewGen Ventures, Abstract Ventures and Tony Ling.
The company intends to use the funds to begin patient rollout, expand into new disease states, grow operations and acquire new customers.
Led by Cory Kidd, CEO and founder, Catalia Health provides a platform that combines artificial intelligence, psychology and medical best practices to deliver everyday care to patients in the United States managing chronic conditions. Its personal healthcare companion, Mabu, supports patients living with chronic illnesses such as rheumatoid arthritis, late-stage kidney disease and congestive heart failure. It completes daily check-ins using tailored conversations with patients to help them manage care routines, overcome the challenges of isolating illnesses and provide insight to healthcare professionals about patient health, progress and adherence to treatment.
The company will begin patient roll out in its first three disease states early 2018.
In addition to the funding, Catalia Health announces Charles Wu as Director of Product Management.